scholarly journals Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study

2015 ◽  
Vol 75 (3) ◽  
pp. 485-493 ◽  
Author(s):  
Jaime R. Merchan ◽  
Rui Qin ◽  
Henry Pitot ◽  
Joel Picus ◽  
Glenn Liu ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Advanced Renal Cell Carcinoma ◽  
Phase 2 ◽  
Previously Treated

Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science

2012 ◽  
Vol 12 (12) ◽  
pp. 1571-1577 ◽  
Author(s):  
Camillo Porta ◽  
Roberto Sabbatini ◽  
Giuseppe Procopio ◽  
Chiara Paglino ◽  
Enzo Galligioni ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Advanced Renal Cell Carcinoma ◽  
Primary Resistance ◽  
State Of The Science

Overall impact of C-reactive protein for advanced renal cell carcinoma treated with tyrosine kinase inhibitors.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e15581-e15581
Author(s):  
Tetsuo Fujita ◽  
Ken-ichi Tabata ◽  
Kazumasa Matsumoto ◽  
Daisuke Ishii ◽  
Kazunari Yoshida ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Advanced Renal Cell Carcinoma ◽  
C Reactive Protein ◽  
Reactive Protein
Sign in / Sign up

Export Citation Format

Share Document